BARDA

BARDA

Biodefense Headlines – 30 December 2024

News Scan December 30, 2024

This week’s selections include California’s declaration of a bird flu emergency (and calls to do so nationally), the first severe case of H5N1 in the U.S., the risks of advancing…

BARDA Exercises Contract Option on Emergent BioSolutions Anthrax Vaccine

Dried Plasma Device for CBRNE Mass Casualty Scenario

New BARDA-Funded Influenza Diagnostic Launched

Cytori to Develop Cell Therapies for Radiation Injury Thermal Burns

Hertfordshire Receives BARDA Award for Mass Casualty Decon Studies

BARDA Announces CBRN Medical Countermeasures Conference

HHS Announces Pandemic Preparedness Contracts to Top Pharma

Ricin Vaccine Shows Positive Phase 1B Clinical Trial Results

BARDA Seeks Antitoxins for Treatment of Inhalational Anthrax

Army to Award Chemical Warfare Agent Research Contract to BBRI

BARDA Multi-BAA Pre-Proposal Conference for CBRN, Influenza Countermeasures

Emergent Biosolutions, Novartis, Texas A&M to Lead New Biodefense Centers

BARDA CBRN Medical Countermeasures Pre-Proposal Conference

SIGA Ordered to Share Biodefense Contract Profits with PharmAthene

BARDA Influenza Drug Awardee Biota Relocating to U.S.

FDA Scrutinizes Home Anthrax Kits

BARDA Extends Deadline for Pandemic Influenza Vaccine Proposals

Senate Reauthorizes Pandemic and All-Hazards Preparedness Act

BARDA to Open New BAA for CBRN Medical Countermeasures

$67.2M Next-Generation Antibiotic Contract Awarded

Biodefense Headlines – 30 December 2024